Even Orchard 5

About

Statute Fern is an independent resource on ibogaine’s Schedule I status and the U.S. legal frameworks surrounding research, possession, and regulation.

Even Orchard 5 exists to make complex, technical regulatory information accessible: we collect, organize, and explain how statutory and administrative material interacts with research and policy. For organizing our content and services, a concise overview of how the site is structured appears below and links naturally to related parts of the site for deeper context.

If you are looking for our practical offerings, our description of available guidance and resources is framed under the site’s services and resource listings, and our front page outlines editorial topics and updates in context with the site’s mission at the root directory Even Orchard 5 overview.

Close-up detail related to ibogaine scheduling discussions, editorial close crop of documents and notes

How our editorial process works

We prioritize a diagram-first explanation: each topic is introduced visually (process maps, node cards, and flow connectors) before detailed text. Visuals clarify relationships among statutes, regulatory guidance, and research pathways so readers can follow how a conclusion is reached without starting from legal jargon.

Our editorial approach

Statute Fern follows a reproducible workflow: identify primary materials (statutes, administrative rules), diagram their relationships, and produce annotated explanations. Where a factual claim relies on an external authority we cite that source inline to make verification straightforward for readers.

For example, when discussing procedural aspects of scheduling or research approvals we consult canonical sources such as the U.S. Code and peer-reviewed registries; in other places we cite explanatory background from established references like the Controlled Substances Act overview on Wikipedia to contextualize statutory structure and use authoritative government guidance for procedural detail such as DEA or FDA materials like FDA guidance. These external citations follow best-practice linking and open in a new tab.

Source transparency

We list the primary sources behind each explanation and annotate diagrams so readers can trace claims back to statutes and regulations.

Independent curation

Content is curated without clinical or commercial claim; the site is not a provider and does not endorse specific treatment providers.

Evidence-first summaries

Summaries begin with visual maps, then present short, referenced prose to support each step of an argument.

What we cover

We cover organizational topics such as how research pathways relate to scheduling, where regulatory notices appear, and how policy developments can affect research programs. When readers are exploring practical options outside the U.S., we describe how to locate reputable treatment directories and clarify that such listings are independent references: for instance, many readers consult directories like affordable treatment directories or directories focused on veterans' care such as resources for veterans, and we discuss how directory information differs from legal analysis.

Organizing research pathways

For researchers mapping approvals and permits, we provide process diagrams and links to regulatory pathways and related services; readers sometimes reference external clinic listings like clinic directories for operational context while keeping legal analysis separate from service endorsement.

Cross-border context

Because treatment and research activity may occur abroad, our practical notes point to common international directories—examples include regional listings such as Mexico center listings and complementary resources at detailed Mexico center directories. These are cited only for context, not as endorsements.

We also point to commercial and research supply sources when relevant to procedural explanation; readers sometimes visit supplier pages such as ibogaine stock and supplier information while following our diagrams to understand regulatory constraints.

Why this resource exists

Even Orchard 5 was created to reduce confusion by separating policy analysis from service listings and to present a clear editorial pipeline for how regulatory findings are supported and qualified. Our mission statement is simple: Statute Fern is an independent resource on ibogaine’s Schedule I status and the U.S. legal frameworks surrounding research, possession, and regulation. We help people distinguish policy developments from changes in law.

Editorial principles

  • Legal accuracy: source claims to primary statutes and rulemaking.
  • Plain language: diagrams and short annotated prose before technical detail.
  • Independence: no clinic endorsements; separation between content and commercial listings.
  • Context over hype: emphasize what is known and where uncertainty remains.
  • Safety: avoid clinical advice; direct readers to appropriate professional channels.

Independent by design

Statute Fern is an independent editorial resource and not a clinic, medical provider, or legal advisor. We do not give medical or legal advice. For official regulatory text and statutory language readers may consult primary law sources and regulatory pages such as the U.S. government's repository for federal regulations at Federal Register or explanatory summaries like those maintained by major academic institutions (for procedural overviews see resources such as academic law centers).

Quick clarifications

This site documents and diagrams public materials. It does not substitute for legal counsel or clinical judgment.

If you are comparing regulations across jurisdictions, diagrams on our pages aim to help you spot procedural differences before consulting primary sources or qualified counsel.

Explore our diagrams and source notes

Start by viewing process maps or browse our services for structured support in tracing regulatory pathways.

Browse services